Literature DB >> 6280603

Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.

W H Beggs, G A Sarosi.   

Abstract

In vitro studies based on periodic viable count determinations indicated that the two antifungal drugs ketoconazole and 5-fluorocytosine generally were at least additive in their combined effect on various opportunistic yeast pathogens, including some resistant to 5-fluorocytosine.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6280603      PMCID： PMC181890          DOI： 10.1128/AAC.21.2.355

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  In vitro synergy and antagonism of antifungal agents against yeast-like fungi.

Authors:  B Dupont; E Drouhet
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

2.  Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.

Authors:  W H Beggs; G A Sarosi; N M Steele
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

Review 3.  Flucytosine.

Authors:  J E Bennet
Journal:  Ann Intern Med       Date:  1977-03       Impact factor: 25.391

4.  Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent.

Authors:  J Heeres; L J Backx; J H Mostmans; J Van Cutsem
Journal:  J Med Chem       Date:  1979-08       Impact factor: 7.446

Review 5.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

6.  Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.

Authors:  J R Graybill; D M Williams; E Van Cutsem; D J Drutz
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

7.  Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients.

Authors:  J R Graybill; D Lundberg; W Donovan; H B Levine; M D Rodriguez; D J Drutz
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

8.  Ketoconazole -- a new broad spectrum orally active antimycotic.

Authors:  D Thienpont; J Van Cutsem; F Van Gerven; J Heeres; P A Janssen
Journal:  Experientia       Date:  1979-05-15

9.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06
  9 in total
  2 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Novel synergism of two antifungal agents, copiamycin and imidazole.

Authors:  J Uno; M L Shigematsu; T Arai
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.